Registry for heart rhythm ablation in VT or PVC
Part of Heart & circulation clinical trials.
This study is a “registry,” meaning it collects information about people undergoing a procedure to treat abnormal heart rhythms like ventricular tachycardia (VT) or premature ventricular contractions (PVCs). It may help researchers better understand which patients benefit from the procedure and how it is done over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be scheduled for a catheter ablation procedure.
- The procedure must be for ventricular tachycardia (VT) or premature ventricular contractions (PVCs).
- You are able to take part in data collection related to your procedure and care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special ultrasound camera on a thin tube inside your heart (intracardiac echocardiography) to help doctors see the area causing your heart rhythm problem more clearly during the standard procedure (ablation). It may help them burn the wrong tissue more precisely.
This study looks at the risk of a fast heart rhythm (ventricular tachycardia) in people with genetic heart muscle diseases. It tests whether having a specific genetic change affects the success of a heart ablation procedure.
This registry collects information about how ventricular tachycardia (a fast heart rhythm from the lower chambers) is managed and the results of different treatments. Participating can help improve future care.
This study compares two ways to treat premature ventricular contractions (extra heartbeats that can cause symptoms). One approach is a catheter ablation (a procedure that destroys the tissue causing the extra beats), and the other is using anti-arrhythmic drugs (medications to control the rhythm). If you have frequent PVCs and a healthy heart, this trial could help you find the best treatment.
This study tests a new device called the DuoVT PFA System to treat ventricular tachycardia, a fast heart rhythm that can be dangerous. It aims to help people who have this condition along with heart disease from a past heart attack, and who have not been helped by medications.
This trial studies how a drug called adenosine helps doctors understand why premature ventricular contractions (PVCs) are happening. The goal is to guide treatment, including catheter ablation, for people with PVCs.
Hear when a new Ventricular Arrhythmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.